537 related articles for article (PubMed ID: 26654942)
1. Diet-derived 25-hydroxyvitamin D3 activates vitamin D receptor target gene expression and suppresses EGFR mutant non-small cell lung cancer growth in vitro and in vivo.
Verone-Boyle AR; Shoemaker S; Attwood K; Morrison CD; Makowski AJ; Battaglia S; Hershberger PA
Oncotarget; 2016 Jan; 7(1):995-1013. PubMed ID: 26654942
[TBL] [Abstract][Full Text] [Related]
2. Without 1α-hydroxylation, the gene expression profile of 25(OH)D
Susa T; Iizuka M; Okinaga H; Tamamori-Adachi M; Okazaki T
Sci Rep; 2018 Jun; 8(1):9024. PubMed ID: 29899561
[TBL] [Abstract][Full Text] [Related]
3. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS
Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461
[TBL] [Abstract][Full Text] [Related]
4. Nongenomic effects of 1α,25-dihydroxyvitamin D
Hirota Y; Nakagawa K; Mimatsu S; Sawada N; Sakaki T; Kubodera N; Kamao M; Tsugawa N; Suhara Y; Okano T
Biochem Biophys Res Commun; 2017 Jan; 483(1):359-365. PubMed ID: 28025137
[TBL] [Abstract][Full Text] [Related]
5. A High-Calcium and Phosphate Rescue Diet and VDR-Expressing Transgenes Normalize Serum Vitamin D Metabolite Profiles and Renal Cyp27b1 and Cyp24a1 Expression in VDR Null Mice.
Kaufmann M; Lee SM; Pike JW; Jones G
Endocrinology; 2015 Dec; 156(12):4388-97. PubMed ID: 26441239
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D(3) metabolism in human glioblastoma multiforme: functionality of CYP27B1 splice variants, metabolism of calcidiol, and effect of calcitriol.
Diesel B; Radermacher J; Bureik M; Bernhardt R; Seifert M; Reichrath J; Fischer U; Meese E
Clin Cancer Res; 2005 Aug; 11(15):5370-80. PubMed ID: 16061850
[TBL] [Abstract][Full Text] [Related]
7. Differential response of lung cancer cell lines to vitamin D derivatives depending on EGFR, KRAS, p53 mutation status and VDR polymorphism.
Maj E; Trynda J; Maj B; Gębura K; Bogunia-Kubik K; Chodyński M; Kutner A; Wietrzyk J
J Steroid Biochem Mol Biol; 2019 Oct; 193():105431. PubMed ID: 31326626
[TBL] [Abstract][Full Text] [Related]
8. Anti-proliferative activity of 25-hydroxyvitamin D3 in human prostate cells.
Munetsuna E; Kawanami R; Nishikawa M; Ikeda S; Nakabayashi S; Yasuda K; Ohta M; Kamakura M; Ikushiro S; Sakaki T
Mol Cell Endocrinol; 2014 Feb; 382(2):960-70. PubMed ID: 24291609
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D-Related Gene Polymorphisms, Plasma 25-Hydroxy-Vitamin D, Cigarette Smoke and Non-Small Cell Lung Cancer (NSCLC) Risk.
Wu X; Cheng J; Yang K
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669215
[TBL] [Abstract][Full Text] [Related]
10. Chronic moderate ethanol intake differentially regulates vitamin D hydroxylases gene expression in kidneys and xenografted breast cancer cells in female mice.
García-Quiroz J; García-Becerra R; Lara-Sotelo G; Avila E; López S; Santos-Martínez N; Halhali A; Ordaz-Rosado D; Barrera D; Olmos-Ortiz A; Ibarra-Sánchez MJ; Esparza-López J; Larrea F; Díaz L
J Steroid Biochem Mol Biol; 2017 Oct; 173():148-156. PubMed ID: 27639478
[TBL] [Abstract][Full Text] [Related]
11. Dietary vitamin D₃ and 1,25-dihydroxyvitamin D₃ (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer.
Swami S; Krishnan AV; Wang JY; Jensen K; Horst R; Albertelli MA; Feldman D
Endocrinology; 2012 Jun; 153(6):2576-87. PubMed ID: 22454149
[TBL] [Abstract][Full Text] [Related]
12. 25(OH)D
Kikuyama T; Susa T; Tamamori-Adachi M; Iizuka M; Akimoto M; Okinaga H; Fujigaki Y; Uchida S; Shibata S; Okazaki T
J Steroid Biochem Mol Biol; 2020 May; 199():105593. PubMed ID: 31945466
[TBL] [Abstract][Full Text] [Related]
13. Human mammary epithelial cells express CYP27B1 and are growth inhibited by 25-hydroxyvitamin D-3, the major circulating form of vitamin D-3.
Kemmis CM; Salvador SM; Smith KM; Welsh J
J Nutr; 2006 Apr; 136(4):887-92. PubMed ID: 16549446
[TBL] [Abstract][Full Text] [Related]
14. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
[TBL] [Abstract][Full Text] [Related]
15. Tumor-Targeted Nanoparticles Deliver a Vitamin D-Based Drug Payload for the Treatment of EGFR Tyrosine Kinase Inhibitor-Resistant Lung Cancer.
Liu C; Shaurova T; Shoemaker S; Petkovich M; Hershberger PA; Wu Y
Mol Pharm; 2018 Aug; 15(8):3216-3226. PubMed ID: 29902012
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of vitamin D₃ metabolite repression of IgE-dependent mast cell activation.
Yip KH; Kolesnikoff N; Yu C; Hauschild N; Taing H; Biggs L; Goltzman D; Gregory PA; Anderson PH; Samuel MS; Galli SJ; Lopez AF; Grimbaldeston MA
J Allergy Clin Immunol; 2014 May; 133(5):1356-64, 1364.e1-14. PubMed ID: 24461581
[TBL] [Abstract][Full Text] [Related]
17. 25-Hydroxyvitamin D(3) is an agonistic vitamin D receptor ligand.
Lou YR; Molnár F; Peräkylä M; Qiao S; Kalueff AV; St-Arnaud R; Carlberg C; Tuohimaa P
J Steroid Biochem Mol Biol; 2010 Feb; 118(3):162-70. PubMed ID: 19944755
[TBL] [Abstract][Full Text] [Related]
18. CYP24, the enzyme that catabolizes the antiproliferative agent vitamin D, is increased in lung cancer.
Parise RA; Egorin MJ; Kanterewicz B; Taimi M; Petkovich M; Lew AM; Chuang SS; Nichols M; El-Hefnawy T; Hershberger PA
Int J Cancer; 2006 Oct; 119(8):1819-28. PubMed ID: 16708384
[TBL] [Abstract][Full Text] [Related]
19. VDR and CYP27B1 are expressed in C2C12 cells and regenerating skeletal muscle: potential role in suppression of myoblast proliferation.
Srikuea R; Zhang X; Park-Sarge OK; Esser KA
Am J Physiol Cell Physiol; 2012 Aug; 303(4):C396-405. PubMed ID: 22648952
[TBL] [Abstract][Full Text] [Related]
20. Differential response to 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3) in non-small cell lung cancer cells with distinct oncogene mutations.
Zhang Q; Kanterewicz B; Shoemaker S; Hu Q; Liu S; Atwood K; Hershberger P
J Steroid Biochem Mol Biol; 2013 Jul; 136():264-70. PubMed ID: 23026510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]